Earlier this month Dr. Patrick Soon-Shiong announced the name of the company that he has been building through a series of acquisitions over the past few years: NantWorks. This week Vodafone announced that it had partnered with NantWorks on researching and developing remote patient care mobile health services over advanced wireless networks. Vodafone recently opened its Silicon Valley-based research center called Vodafone Xone and NantWorks participated during its launch event along with other likely Voda partners.
Following the sales of two companies Soon-Shiong founded — American Pharmaceutical Partners (sold 2008) and Abraxis BioScience (sold 2010) — he has invested more than $400 million dollars in acquisitions. In February Soon-Shiong acquired GlowCaps maker Vitality for an undisclosed sum thought to be in the low tens of millions. GlowCaps made an appearance at the Vodafone Xone event, which makes it likely the device is part of NantWorks.
NantWorks other portfolio of companies and offerings include: “state of the art semiconductor chips, switches and encryption technologies, augmented reality, novel object and voice recognition technologies, broadband telecommunications services and ultra-low power remote monitoring devices,” according to its launch press release.
“With Vodafone’s global mobile network, and its partner Verizon Wireless here in the United States, Vodafone is truly a global mobile powerhouse,” Soon-Shiong stated in a press release. “It is the ideal partner for NantWorks to work with as we develop the technologies that will bring the digital revolution to more aspects of people’s lives, including healthcare and education.”
For more on NantWorks deal with Vodafone, read the press release after the jump. Keep reading>>